Form 8-K - Current report:
SEC Accession No. 0001206774-20-003032
Filing Date
2020-11-05
Accepted
2020-11-05 16:32:24
Documents
14
Period of Report
2020-11-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT geron3826481-8k.htm   iXBRL 8-K 25459
2 PRESS RELEASE DATED NOVEMBER 5, 2020 geron3826481-ex991.htm EX-99.1 65205
6 GRAPHIC geron3826481-ex991x1x1.jpg GRAPHIC 4374
  Complete submission text file 0001206774-20-003032.txt   281173

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA gern-20201105.xsd EX-101.SCH 3177
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gern-20201105_pre.xml EX-101.PRE 22704
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE gern-20201105_lab.xml EX-101.LAB 34591
7 EXTRACTED XBRL INSTANCE DOCUMENT geron3826481-8k_htm.xml XML 3591
Mailing Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404
Business Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

EIN.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-20859 | Film No.: 201290993
SIC: 2834 Pharmaceutical Preparations